Skip to main content

Exploration of components contributing to potent cytotoxicity of Gardenia thunbergia L. f. against human leukemia and hepatoma

Research Authors
Shaymaa M. Mohamed, Samir A. Ross, Nesma M. Mohamed
Research Date
Research Department
Research Journal
Bulletin of Pharmaceutical Sciences, Assiut
Research Publisher
-
Research Vol
45
Research Website
https://bpsa.journals.ekb.eg/article_239374.html
Research Year
2022
Research_Pages
153-162
Research Abstract

Promising cytotoxic effects of several Gardenia species (Rubiaceae) have been established 
by many studies. The current study evaluated MTT-based cytotoxic activities of the crude 
extract from Gardenia thunbergia L. f. aerial parts and four fractions thereof, including n-hexane, dichloromethane (DCM), ethyl acetate, and aqueous, against human leukemia (HL-60) 
and hepatoma (HepG2) cell lines, as well as the normal (WI38) cell line. Both non-polar 
fractions, n-hexane and dichloromethane, showed tumor-selective toxicities against both tested 
cancerous cell lines. These results sparked our interest in chemically characterising these 
bioactive fractions to reveal their cytotoxic components. The composition of n-hexane-soluble 
fraction was investigated via GC-MS analysis, while column chromatographic separation was 
used to isolate the components of DCM-soluble fraction. These isolated phytochemicals were 
identified via spectroscopic analyses. Besides, the chemotaxonomic value of the detected 
phytochemicals and their reported cytotoxic profiles were discussed